|
|
|
Insider
Information: |
Susman Sally |
Relationship: |
Executive Vice President |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
164,091 |
|
Indirect Shares
|
813 |
|
|
Direct
Value |
$4,609,506 |
|
|
Indirect Value
|
$21,349 |
|
|
Total
Shares |
164,904 |
|
|
Total
Value |
$4,630,856 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-9.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Estee Lauder Companies Inc |
EL |
Exec.VP, Global Commun... |
2007-10-31 |
2,480 |
2004-12-03 |
0 |
Premium* |
|
Pfizer Inc |
PFE |
Executive Vice President |
2024-02-23 |
161,611 |
2024-02-23 |
813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PFE |
Pfizer Inc |
Executive Vice President |
|
2024-02-23 |
4 |
D |
$27.37 |
$1,549,347 |
D/D |
(56,537) |
161,611 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2024-02-23 |
4 |
OE |
$27.34 |
$1,745,304 |
D/D |
63,837 |
218,148 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2023-02-25 |
4 |
D |
$41.75 |
$2,345,588 |
D/D |
(54,868) |
154,311 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2023-02-25 |
4 |
OE |
$22.89 |
$1,670,604 |
D/D |
72,984 |
209,179 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2023-02-22 |
4 |
OE |
$30.17 |
$2,294,217 |
D/D |
76,043 |
195,493 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2023-02-22 |
4 |
D |
$42.38 |
$2,574,153 |
D/D |
(59,298) |
136,195 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2022-05-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
119,450 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2022-02-26 |
4 |
D |
$47.72 |
$2,397,760 |
D/D |
(48,430) |
124,450 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2022-02-26 |
4 |
OE |
$25.60 |
$1,627,648 |
D/D |
63,580 |
172,880 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2022-02-23 |
4 |
D |
$46.87 |
$2,847,403 |
D/D |
(57,170) |
109,300 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2022-02-23 |
4 |
OE |
$27.34 |
$2,102,309 |
D/D |
76,895 |
166,470 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2021-11-26 |
4 |
S |
$54.43 |
$2,415,578 |
D/D |
(44,308) |
89,575 |
0 |
% |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2021-02-27 |
4 |
OE |
$22.35 |
$1,606,943 |
D/D |
71,899 |
193,474 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2021-02-27 |
4 |
D |
$33.49 |
$2,048,128 |
D/D |
(59,591) |
133,883 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2021-02-25 |
4 |
D |
$33.82 |
$2,355,800 |
D/D |
(68,188) |
121,575 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2021-02-25 |
4 |
OE |
$22.89 |
$1,869,358 |
D/D |
81,667 |
189,763 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2020-11-09 |
4 |
AS |
$41.94 |
$1,831,184 |
D/D |
(43,662) |
108,096 |
0 |
% |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2020-02-28 |
4 |
D |
$33.42 |
$2,507,144 |
D/D |
(70,738) |
151,758 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2020-02-28 |
4 |
OE |
$27.37 |
$2,501,837 |
D/D |
91,408 |
222,496 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2020-02-26 |
4 |
OE |
$34.59 |
$2,506,530 |
D/D |
72,464 |
180,558 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,783 |
203,341 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2020-02-26 |
4 |
D |
$34.72 |
$2,623,675 |
D/D |
(72,253) |
131,088 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2019-03-04 |
4 |
AS |
$42.90 |
$377,444 |
D/D |
(8,725) |
172,094 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2019-03-04 |
4 |
AS |
$42.89 |
$2,760,698 |
D/D |
(63,998) |
108,096 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2019-02-27 |
4 |
OE |
$32.23 |
$2,764,141 |
D/D |
85,763 |
228,743 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|